{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:13:18Z","timestamp":1784772798123,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of this study was to identify the main features of a cohort of Caucasian patients with idiopathic (I) and systemic disease-associated (SDA) autoimmune uveitis (AU) who were followed up at a single tertiary reference center. The study consisted of a retrospective analysis of the demographic, clinical, and laboratory features and the response to treatment of 104 patients with AU evaluated between 2004 and 2013, with a median follow-up of 4.8\u00a0years. The primary outcome measure was the response to systemic treatment after 24\u00a0months of therapy. The data are expressed as the range, percentage, or mean\u2009\u00b1\u2009standard error. Categorical variables were assessed by Fisher's exact test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean age at diagnosis was 40.1\u2009\u00b1\u200917.8\u00a0years for men and 44.1\u2009\u00b1\u200915.3\u00a0years for women. There was a slight female predominance. Of the 104 patients, 72.1% had I-AU and 27.9% SDA-AU. The most frequent associations were with ankylosing spondyloarthritis, autoimmune thyroiditis, inflammatory bowel diseases, and Behcet's disease. Symptoms at presentation consisted of eye redness and pain (28.8%), decreased visual acuity (25.9%), and floaters (18.3%). Complications included cataracts (24%), retinal neovascularization (16.3%), chorio-retinal scars (10.6%), cystoid macular edema (8.6%), glaucoma\/ocular hypertension (7.7%), epiretinal membranes (4.8%), and retinal detachment (3.8%). The prevalence of autoantibodies, mostly antinuclear antibodies, was comparable between the I-AU and SDA-AU groups. Fisher's exact test showed a direct correlation between patients with class I HLA B27, Cw8, B5 (51, 52), B51, or Cw2 and the presence of AU, whereas among patients with class II HLA, only DQ1 was a predisposing factor for AU. The therapeutic spectrum included corticosteroids and immunosuppressive agents, given either alone or in various combinations according to the severity of AU and the extent of the clinical response. Among the immunosuppressive drugs, azathioprine was preferentially used for anterior uveitis, and cyclosporine-A for intermediate and posterior uveitis. An assessment of the patients after 24\u00a0months of therapy showed a complete remission in 43.3% and a significant clinical improvement in 26.9%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>At our tertiary reference center, the prevalence in Caucasian patients of I-AU was approximately 2.5-fold higher than that of SDA-AU. Our findings point to the need for a patient-tailored therapeutic approach according to the anatomic site and the severity of AU. Therapy should be prolonged, over a period of months and even up to 1\u20132 years, in order to achieve stable control of the disease and to prevent severe complications. The outcome of SDA-AU is also influenced by treatment of the underlying systemic disease. Additional controlled trials are needed to assess the efficacy and the long-term safety of both the prescribed therapeutic agents and their combinations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12348-014-0017-9","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T10:43:58Z","timestamp":1406112238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center"],"prefix":"10.1186","volume":"4","author":[{"given":"Marcella","family":"Prete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Celeste","family":"Fatone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG: Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004, 111: 491\u2013500. 10.1016\/j.ophtha.2003.06.014","journal-title":"Ophthalmology"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1755-3768.2008.01282.x","volume":"87","author":"H Kitamei","year":"2009","unstructured":"Kitamei H, Kitaichi N, Namba K, Kotake S, Goda C, Kitamura M, Miyazaki A, Ohno S: Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009, 87: 424\u2013428. 10.1111\/j.1755-3768.2008.01282.x","journal-title":"Acta Ophthalmol"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1172\/JCI42440","volume":"120","author":"RR Caspi","year":"2010","unstructured":"Caspi RR: A look at autoimmunity and inflammation in the eye. J Clin Invest 2010, 120: 3073\u20133083. 10.1172\/JCI42440","journal-title":"J Clin Invest"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1750-1172-7-57","volume":"7","author":"T Barisani-Asenbauer","year":"2012","unstructured":"Barisani-Asenbauer T, Maca SM, Mejdoubi L, Emminger W, Machold K, Auer H: Uveitis - a rare disease often associated with systemic diseases and infections - a systematic review of 2619 patients. Orphanet J Rare Dis 2012, 7: 57. 10.1186\/1750-1172-7-57","journal-title":"Orphanet J Rare Dis"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0301-4738.31936","volume":"55","author":"SR Rathinam","year":"2007","unstructured":"Rathinam SR, Namperumalsamy P: Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007, 55: 173\u201383. 10.4103\/0301-4738.31936","journal-title":"Indian J Ophthalmol"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005, 140: 509\u2013516. 10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/14728214.2011.537824","volume":"16","author":"T Larson","year":"2011","unstructured":"Larson T, Nussenblatt RB, Sen HN: Emerging drugs for uveitis. Expert Opin Emerg Drugs 2011, 16: 309\u2013322. 10.1517\/14728214.2011.537824","journal-title":"Expert Opin Emerg Drugs"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1034\/j.1600-0420.2001.079001064.x","volume":"79","author":"A Mercanti","year":"2001","unstructured":"Mercanti A, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L: Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 2001, 79: 64\u20138. 10.1034\/j.1600-0420.2001.079001064.x","journal-title":"Acta Ophthalmol Scand"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1442-9071.2009.02102.x","volume":"37","author":"H Keino","year":"2009","unstructured":"Keino H, Nakashima C, Watanabe T, Taki W, Hayakawa R, Sugitani A, Okada AA: Frequency and clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol 2009, 37: 595\u2013601. 10.1111\/j.1442-9071.2009.02102.x","journal-title":"Clin Experiment Ophthalmol"},{"key":"17_CR10","volume-title":"Ocul Immunol Inflamm","author":"NP Jones","year":"2013","unstructured":"Jones NP (2013): The Manchester Uveitis clinic: the first 3000 patients-epidemiology and casemix. Ocul Immunol Inflamm Dec 2 Epub ahead of print)"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11882-013-0409-1","volume":"14","author":"J Pan","year":"2014","unstructured":"Pan J, Kapur M, McCallum R: Noninfectious immune-mediated uveitis and ocular inflammation. Curr Allergy Asthma Rep 2014, 14: 409. 10.1007\/s11882-013-0409-1","journal-title":"Curr Allergy Asthma Rep"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/09273940903348835","volume":"18","author":"M Khairallah","year":"2010","unstructured":"Khairallah M: Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm 2010, 18: 2\u20134. 10.3109\/09273940903348835","journal-title":"Ocul Immunol Inflamm"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/art.1780400221","volume":"40","author":"A Banares","year":"1997","unstructured":"Banares A, Jover JA, Benitez F-G, del Castillo JM, Garcia J, Vargas E, Hernandez-Garcia C: Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis Rheum 1997, 40: 358\u2013370. 10.1002\/art.1780400221","journal-title":"Arthritis Rheum"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","volume":"145","author":"P Lin","year":"2008","unstructured":"Lin P, Bhullar SS, Tessler HH, Goldstein DA: Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol 2008, 145: 463\u2013471. 10.1016\/j.ajo.2007.09.024","journal-title":"Am J Ophthalmol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/09273948.2011.559302","volume":"19","author":"TM Martin","year":"2011","unstructured":"Martin TM, Rosenbaum JT: An update on the genetics of HLA B27-associated acute anterior uveitis. Ocul Immunol Inflamm 2011, 19: 108\u2013114. 10.3109\/09273948.2011.559302","journal-title":"Ocul Immunol Inflamm"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0002-9394(00)00863-1","volume":"131","author":"S Oruc","year":"2001","unstructured":"Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ: The association of HLA class II with pars planitis. Am J Ophthalmol 2001, 131: 657\u2013659. 10.1016\/S0002-9394(00)00863-1","journal-title":"Am J Ophthalmol"},{"key":"17_CR17","first-page":"184","volume":"19","author":"D Atan","year":"2013","unstructured":"Atan D, Heissigerova J, Kuffova L, Hogan A, Kilmartin DJ, Forrester JV, Bidwell JL, Dick AD, Churchill AJ: Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vis 2013, 19: 184\u2013195.","journal-title":"Mol Vis"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/jir.2011.0042","volume":"31","author":"R Horai","year":"2011","unstructured":"Horai R, Caspi RR: Cytokines in autoimmune uveitis. J Interferon Cytokine Res 2011, 31: 733\u2013744. 10.1089\/jir.2011.0042","journal-title":"J Interferon Cytokine Res"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1167\/iovs.05-1547","volume":"47","author":"S Sugita","year":"2006","unstructured":"Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M: Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006, 47: 2547\u20132554. 10.1167\/iovs.05-1547","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1167\/iovs.04-1273","volume":"46","author":"FM Damico","year":"2005","unstructured":"Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH: T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 2005, 46: 2465\u20132471. 10.1167\/iovs.04-1273","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"e29742","DOI":"10.1371\/journal.pone.0029742","volume":"7","author":"CR Yu","year":"2012","unstructured":"Yu CR, Lee YS, Mahdi RM, Surendran N, Egwuagu CE: Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. PLoS One 2012, 7: e29742. 10.1371\/journal.pone.0029742","journal-title":"PLoS One"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/eye.2011.255","volume":"26","author":"RW Lee","year":"2012","unstructured":"Lee RW, Dick AD: Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond) 2012, 26: 17\u201328. 10.1038\/eye.2011.255","journal-title":"Eye (Lond)"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjo.2005.072686","volume":"90","author":"JH Chang","year":"2006","unstructured":"Chang JH, McCluskey PJ, Wakefield D: Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 2006, 90: 103\u2013108. 10.1136\/bjo.2005.072686","journal-title":"Br J Ophthalmol"},{"key":"17_CR24","first-page":"2970","volume":"17","author":"DS Pratap","year":"2011","unstructured":"Pratap DS, Lim LL, Wang JJ, Mackey DA, Kearns LS, Stawell RJ, Burdon KP, Mitchell P, Craig JE, Hall AJ, Hewitt AW: The role of toll-like receptor variants in acute anterior uveitis. Mol Vis 2011, 17: 2970\u20132977.","journal-title":"Mol Vis"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/s10165-008-0064-x","volume":"18","author":"Y Nanke","year":"2008","unstructured":"Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N: Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol 2008, 18: 354\u2013358. 10.3109\/s10165-008-0064-x","journal-title":"Mod Rheumatol"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1167\/iovs.08-1793","volume":"49","author":"L Chen","year":"2008","unstructured":"Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A: Diminished frequency and function of CD4\u2009+\u2009CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 2008, 49: 3475\u20133482. 10.1167\/iovs.08-1793","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/09273948.2012.681830","volume":"20","author":"S Ruggieri","year":"2012","unstructured":"Ruggieri S, Frassanito MA, Dammacco R, Guerriero S: Treg lymphocytes in autoimmune uveitis. Ocul Immunol Inflamm 2012, 20: 255\u2013261. 10.3109\/09273948.2012.681830","journal-title":"Ocul Immunol Inflamm"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.semarthrit.2010.05.008","volume":"40","author":"E Pato","year":"2011","unstructured":"Pato E, Munoz-Fernandez S, Francisco F, Abad MA, Maese J, Ortiz A, Carmona L: Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. Semin Arthritis Rheum 2011, 40: 314\u2013323. 10.1016\/j.semarthrit.2010.05.008","journal-title":"Semin Arthritis Rheum"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12016-011-8267-x","volume":"41","author":"RA Levy","year":"2011","unstructured":"Levy RA, de Andrade FA, Foeldvari I: Cutting-edge issues in autoimmune uveitis. Clin Rev Allergy Immunol 2011, 41: 214\u2013223. 10.1007\/s12016-011-8267-x","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-014-0017-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-014-0017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-014-0017-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-014-0017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:49:34Z","timestamp":1630558174000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-014-0017-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1186\/s12348-014-0017-9","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]},"assertion":[{"value":"28 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}